NLRP3 and kidney disorder: More importantly, our study identified Bcl-2 as a negative regulator of ZIKV-induced NLRP3 inflammasome activation and renal cell apoptosis, which provided a new insight of the therapeutic target for renal diseases induced by viral infection.